Salveen Richter Analyst PerformanceManaging Director, Global Investment Research at The Goldman Sachs GroupSalveen Richter is a stock analyst at The Goldman Sachs Group focused in the medical sector, covering 30 publicly traded companies. Over the past year, Salveen Richter has issued 34 stock ratings, including buy, hold, and sell recommendations. While full access to Salveen Richter's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Salveen Richter's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings64 Last 11 YearsBuy Recommendations46.88% 30 Buy RatingsCompanies Covered30 Unique Companies Ratings Distribution64RatingsDistribution of strong buy, buy, hold, and sell ratings by Salveen Richter.RatingPercentageCount Strong Buy1.6%1 ratings Buy45.3%29 ratings Hold45.3%29 ratings Sell7.8%5 ratingsOut of 64 total stock ratings issued by Salveen Richter at The Goldman Sachs Group, the majority (45.3%) have been Buy recommendations, followed by 45.3% Hold, 7.8% Sell, and 1.6% Strong Buy.Best & Worst CallsBest Call0000.0%FDMTMay 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%SGENFeb 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ96.7% of companies on NASDAQ29 companiesNYSE3.3% of companies on NYSE1 companySalveen Richter, an analyst at The Goldman Sachs Group, currently covers 30 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical29 companies96.7%Manufacturing1 company3.3%Salveen Richter of The Goldman Sachs Group specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE22 companies73.3%MED - DRUGS5 companies16.7%BIOTECHNOLOGY2 companies6.7%Miscellaneous1 company3.3% Salveen Richter's Ratings History at The Goldman Sachs Group Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsIONSIonis Pharmaceuticals6/24/2026Boost Price Target$76.52$75.00Neutral$0.0000.00% ROIQUREuniQure6/18/2026Boost Price Target$48.16$46.00Neutral$0.0000.00% ROIANNXAnnexon5/12/2026Initiated Coverage$5.68$7.00Neutral$0.0000.00% ROIANNXAnnexon5/12/2026Initiated Coverage$5.44$7.00Neutral$0.0000.00% ROIBMRNBioMarin Pharmaceutical5/11/2026Initiated Coverage$54.06$69.00Neutral$0.0000.00% ROIELVNEnliven Therapeutics5/8/2026Boost Price Target$40.48$59.00Buy$0.0000.00% ROIMRNAModerna5/1/2026Boost Price Target$45.37$49.00Neutral$0.0000.00% ROIRLAYRelay Therapeutics4/28/2026Boost Price Target$14.95$22.00Buy$0.0000.00% ROINTLAIntellia Therapeutics4/28/2026Boost Price Target$13.01$9.00Sell$0.0000.00% ROIQUREuniQure4/20/2026Boost Price Target$17.58$10.00Neutral$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. AGIOAgios Pharmaceuticals4/1/2026Boost Price Target$34.38$32.00Neutral$0.0000.00% ROIDNLIDenali Therapeutics3/26/2026Boost Price Target$20.65$40.00Buy$0.0000.00% ROIRAREUltragenyx Pharmaceutical3/24/2026Downgrade$20.27$25.00Neutral$0.0000.00% ROIGENBGenerate Biomedicines3/24/2026Initiated Coverage$12.52$26.00Buy$0.0000.00% ROIQUREuniQure3/3/2026Lower Price Target$9.07$9.00Neutral$0.0000.00% ROIMRNAModerna2/17/2026Boost Price Target$42.48$41.00Neutral$0.0000.00% ROIBIIBBiogen2/9/2026Reiterated Rating$195.33Buy$0.0000.00% ROIRCUSArcus Biosciences1/12/2026Upgrade$21.25$28.00Buy$0.0000.00% ROIAPLSApellis Pharmaceuticals1/12/2026Reiterated Rating$23.20$19.00Sell$0.0000.00% ROIBIIBBiogen1/8/2026Reiterated Rating$186.91$225.00Buy$0.0000.00% ROIAGIOAgios Pharmaceuticals11/20/2025Lower Price Target$22.34$25.00Neutral$0.0000.00% ROIFOLDAmicus Therapeutics11/5/2025Boost Price Target$9.26$11.00Neutral$0.0000.00% ROIQUREuniQure11/4/2025Lower Price Target$34.29$38.00Neutral$0.0000.00% ROIRCUSArcus Biosciences10/30/2025Boost Price Target$20.21$16.00Neutral$0.0000.00% ROIIONSIonis Pharmaceuticals9/26/2025Upgrade$62.97$65.00Neutral$0.0000.00% ROIAPLSApellis Pharmaceuticals9/26/2025Downgrade$22.22$18.00Sell$0.0000.00% ROIQUREuniQure9/25/2025Boost Price Target$49.99$56.00Neutral$0.0000.00% ROIIMNMImmunome9/22/2025Initiated Coverage$9.39$26.00Buy$0.0000.00% ROIIMNMImmunome9/22/2025Initiated Coverage$9.77$26.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals9/16/2025Boost Price Target$461.42$566.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals9/3/2025Boost Price Target$61.17$45.00Sell$0.0000.00% ROIFDMT4D Molecular Therapeutics8/12/2025Lower Price Target$6.17$38.00Buy$0.0000.00% ROISRPTSarepta Therapeutics8/7/2025Boost Price Target$17.42$19.00Neutral$0.0000.00% ROIACADACADIA Pharmaceuticals8/7/2025Boost Price Target$23.89$17.00Sell$0.0000.00% ROISRPTSarepta Therapeutics6/17/2025Downgrade$22.03$29.00Hold$00.0000.00% ROIELVNEnliven Therapeutics6/16/2025Initiated Coverage$21.91$37.00Buy$00.0000.00% ROIFDMT4D Molecular Therapeutics5/9/2025Lower Price Target$3.06$44.00Buy$00.0000.00% ROIRCUSArcus Biosciences5/8/2025Lower Price Target$8.14$13.00Neutral$00.0000.00% ROICRSPCRISPR Therapeutics5/8/2025Lower Price Target$35.40$47.00Neutral$00.0000.00% ROISRPTSarepta Therapeutics5/7/2025Lower Price Target$37.52$100.00Buy$00.0000.00% ROIBuy the “unseen winner of the AI race” before July 22 (Ad)Marc Chaikin - the analyst who called Nvidia before a 45,000% surge - says one overlooked AI stock could split into three separate companies in a rare event called a 'starburst' before July 22. Investors who buy shares before the announcement could automatically receive equal shares in each spinoff. A similar starburst at GE unlocked $184 billion for shareholders across three new companies.Get the full details on this AI starburst opportunity before July 22BMRNBioMarin Pharmaceutical5/5/2025Lower Price Target$62.48$104.00Buy$00.0000.00% ROIFOLDAmicus Therapeutics5/2/2025Lower Price Target$6.56$9.00Neutral$0.0000.00% ROIREGNRegeneron Pharmaceuticals4/30/2025Lower Price Target$590.09$804.00Buy$000.0000.00% ROIBIIBBiogen4/23/2025Lower Price Target$120.33$197.00Buy$000.0000.00% ROIREGNRegeneron Pharmaceuticals4/14/2025Lower Price Target$560.49$917.00Buy$000.0000.00% ROIADPTAdaptive Biotechnologies3/21/2025Upgrade$7.75$9.00Buy$00.0000.00% ROISMMTSummit Therapeutics2/28/2025Initiated Coverage$18.49$42.00Buy$00.0000.00% ROICRSPCRISPR Therapeutics2/13/2025Lower Price Target$42.93$57.00Neutral$00.0000.00% ROIBIIBBiogen2/13/2025Lower Price Target$136.88$245.00Buy$000.0000.00% ROIGILDGilead Sciences2/12/2025Boost Price Target$103.52$96.00Neutral$000.0000.00% ROIMRNAModerna1/29/2025Downgrade$44.94$51.00Neutral$00.0000.00% ROIMRNAModerna1/28/2025Lower Price Target$43.47$99.00Buy$00.0000.00% ROIDNLIDenali Therapeutics1/28/2025Lower Price Target$22.99$40.00Buy$00.0000.00% ROIADPTAdaptive Biotechnologies1/28/2025Boost Price Target$7.76$7.50Neutral$00.0000.00% ROINTLAIntellia Therapeutics1/14/2025Lower Price Target$10.05$12.00Neutral$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysMorgan StanleyRoyal Bank Of CanadaWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupDeutsche Bank AktiengesellschaftRaymond James FinancialBMO Capital MarketsNational Bank FinancialBerenberg Bank Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
